Navigation Links
Assay Designs(TM) Announces Additions to the Leadership Team

ANN ARBOR, Mich., Oct. 1 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life sciences and translational research markets, announced two key additions to its senior leadership team:

- Michael Mullenix, PhD, has joined the company as Vice President,

Research and Development. Dr. Mullenix comes to Assay Designs from

Amgen in Thousand Oaks, CA, where he was a Principal Scientist in their

Clinical Immunology group, responsible for a team of scientists

dedicated to the development of GLP compliant immunoassays for

preclinical and clinical trials. Prior to joining Amgen, Dr. Mullenix

held a series of R&D leadership positions with Molecular Staging,

Becton Dickinson, and Strategic Diagnostics.

- Gabriella Szekely-Klepser, PhD, joined Assay Designs as Vice President,

Science and Technology. Dr. Szekely-Klepser was previously an Associate

Research Fellow at Pfizer Global R&D in Ann Arbor, where she was most

recently leader of the Translational Research Biomarker Implementation

and Biologics Bioanalytical Groups. Prior to her six years at Pfizer,

Dr. Szekely-Klepser held various R&D positions at 3M Corporation.

"We are thrilled at having Mike and Gabriella join Assay Designs," stated Dan Calvo, President and CEO. "Mike has a unique blend of assay development experience from Amgen, coupled with an extensive track record of launching innovative immunoassay kit and reagent products earlier in his career. He knows how to drive an innovative and productive R&D pipeline from concept to launch. Gabriella led the establishment and expansion of Pfizer's biomarker programs across many of its therapeutic areas. She also worked closely with several key CROs to translate and scale-up complex assays. Her experience in developing and validating biomarker assays, and her understanding of the critical success factors for these programs within drug development sponsors, are a perfect match with our growth strategy," continued Calvo.

"Mike and Gabriella are joining Assay Designs at a pivotal and exciting time," further stated Mr. Calvo. "Since April, we have expanded our commercial team with the addition of three key individuals: Maziar Younessian, Director of Marketing and formerly with Invitrogen, Dr. Dana Haley-Vicente, Senior Product Manager and formerly with Accelrys, and Robert Moynihan, Manager for our International business and formerly with Perkin Elmer Life Sciences. We have also promoted Dr. Rob Christener to the new role of General Manager for our growing reagents business, spear-headed by our Stressgen(R) product line."

Mr. Calvo continued, "With this new team in place, we are poised to expand our line of innovative kits and reagents in our core inflammation and steroids/hormone businesses, as well as expand our line of market-leading heat shock and oxidative stress reagents and kits under the Stressgen brand name. We have recently launched a line of unique, activation-state specific antibodies that distinguish between the active and passive forms of numerous GPCRs. Our new and expanded team will build upon this product portfolio, as well as drive the expansion of our business into the biomarker and clinical trial services space."

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops, manufactures and markets immunoassay (ELISA) kits, antibodies, and proteins that are used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use its products to detect and quantify molecules that are important in inflammation, heat shock, cell signaling, and oxidative stress.

SOURCE Assay Designs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" )
3. Organize Your Data from the Big Blue Mutation Assay
4. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
5. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
6. LiquiChip Kits for bead-based cytokine and kinase assays
7. RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes
8. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
9. measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay
10. High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system
11. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 ... is dominated by a few companies, according to Kalorama ... own 51% of the market share of the 6.1 ... The World Market for Molecular Diagnostic s . ... "The market is still controlled by one company and ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
Breaking Biology News(10 mins):